Relay Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Relay Therapeutics, Inc. (RLAY) on July 21, 2020, covering events occurring on July 15, 2020. The filing relates to corporate governance amendments executed in connection with the consummation of the Company's Initial Public Offering (IPO), which was scheduled for July 20, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and structural amendments rather than financial performance data.
Material Changes
The Company implemented significant changes to its governing documents effective upon the IPO:
- Certificate of Incorporation: Filed a Fourth Amended and Restated Certificate of Incorporation with the State of Delaware. This document authorizes 150,000,000 shares of common stock, eliminates all references to previously existing preferred stock, and authorizes 10,000,000 shares of undesignated preferred stock.
- Bylaws: Amended and Restated Bylaws became effective on July 15, 2020. Key changes include eliminating the ability of stockholders to take action by written consent or call special meetings, and establishing specific procedures for stockholder proposals and director nominations.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors beyond the standard incorporation of the new governing documents. The primary context is the transition to a public company structure.
Key Facts for Investor Verification
- Verify the final share count and capital structure post-IPO as authorized by the new Certificate of Incorporation.
- Confirm the elimination of prior preferred stock series and the terms of the new undesignated preferred stock.
- Note the restriction on stockholder actions by written consent, requiring all actions to be taken at meetings.
- Review the attached Exhibits 3.1 and 3.2 for the full legal text of the Restated Certificate and Bylaws.